Marketing Director

Concord, CA (Hybrid)

$195K/yr – $248K/yrSenior Level10+ years expFull time

Posted 7 weeks ago

Top 1% of applicants do these two things.

The other 99% submit and hope. You're about to do something different.

Job Summary

Own the end-to-end launch and commercialization of regulated healthcare products, coordinating messaging, field readiness, and multi-channel campaigns across hospitals, physicians, and blood centers.

  • Launch ownership: plan, align cross-functionally, and drive customer adoption and market development for new indications and geographies.
  • Strategic marketing: translate research, competitive intelligence, and clinical data into actionable strategies and integrated plans.
  • Channel mix: manage collateral, digital, congress, peer-to-peer, advocacy, and field initiatives with sales and market development partners.

Job Description

Responsibilities

  • Lead launch planning and commercialization activities for new products, indications, and geographic expansions, including launch readiness, market development, messaging, and customer adoption strategies.
  • Develop and execute integrated marketing plans aligned with corporate and commercial objectives.
  • Partner with cross-functional stakeholders to ensure successful execution of launch milestones, customer engagement plans, and field readiness initiatives.
  • Drive segmentation, positioning, and value proposition development across target customer groups, including hospitals, blood centers, physicians, and healthcare administrators.
  • Translate market research, customer insights, competitive intelligence, and clinical data into actionable marketing strategies.
  • Develop and oversee multi-channel marketing campaigns, including collateral, digital, congress, peer-to-peer, advocacy, and field-based initiatives.
  • Lead communication planning, content strategy, and development of promotional and educational materials across customer audiences.
  • Partner with Sales and market development teams to optimize customer engagement and ensure alignment between strategy and regional execution.
  • Support development of customer journey strategies and omnichannel engagement approaches to improve customer experience and commercial performance.
  • Manage advisory boards, speaker bureau, advocate development programs, and key external stakeholder engagement activities.
Cerus logo

Cerus

3.7 Glassdoor

Cerus Corporation is dedicated solely to safeguarding the world’s blood supply and aims to become the preeminent global blood products company. Headquartered in Concord, California, the company develops and supplies vital technologies and pathogen-protected blood components to blood centers, hospitals, and ultimately patients who rely on safe blood. The INTERCEPT Blood System for platelets and plasma is available globally and remains the only pathogen reduction system with both CE mark and FDA approval for these two blood components. In the US, the INTERCEPT Blood System for Cryoprecipitation is approved for the production of Pathogen Reduced Cryoprecipitated Fibrinogen Complex (commonly referred to as INTERCEPT Fibrinogen Complex), a therapeutic product for the treatment and control of bleeding, including massive hemorrhage, associated with fibrinogen deficiency. The INTERCEPT red blood cell system is in late-stage clinical development. For more information about Cerus, visit www.cerus.com and follow us on LinkedIn.

Founded in 1992
Concord, California, USA
380 employees (14 in marketing)
65% recommend to a friend
86% CEO approval

Traffic Signals

Monthly Visitors
8.9K
Traffic Source Mix
Search
37.7%
Direct
44.1%
Referral
6.3%
Social
10.7%
Paid
1.1%

Headcount Trend

Current headcount: ~387

Marketing Team

Marketing Team Size
13 (3% of company)
Median Career Experience
27 years
Median Tenure
9.8 years
Marketing Roles Posted (Last 30 Days)
1

Funding

Total Funding
$235.8M
Last Raise
$63.3M
Post IPO Equity, 6 years ago

Funding History

  • Jan 2020
    Post IPO Equity • $63.3M
  • May 2018
    Grant • $15M
  • Jan 2018
    Post IPO Equity • $57.5M